The recent development of therapeutic approaches for Duchenne muscular dystrophy
(DMD) has highlighted the need to identify clinical outcome measures for planned efficacy …

Facioscapulohumeral muscular dystrophy (FSHD) is a debilitating muscular dystrophy with a
variable age of onset, severity, and progression. While there is still no cure for this disease …

Objective: To develop a patient-based, linearly weighted scale that captures activity and
social participation limitations in patients with Guillain-Barré syndrome (GBS), chronic …

Abstract The Medical Research Council grading system has served through decades for the
evaluation of muscle strength and has been recognized as a cardinal feature of daily …

Background and objective Dysferlinopathies are a group of muscle disorders caused by
mutations in the DYSF gene. Previous muscle imaging studies describe a selective pattern …

There are growing numbers of adults with Duchenne Muscular Dystrophy living well into
their fourth decade. These patients have complex medical needs that to date have not been …

To evaluate differences in qMRI parameters of muscle diffusion tensor imaging (mDTI), fat-
fraction (FF) and water T2 time in leg muscles of calpainopathy patients (LGMD R1/D4) …

Late onset Pompe disease (LOPD) is a slow, progressive disorder characterized by skeletal
and respiratory muscle weakness. Enzyme replacement therapy (ERT) slows down the …

Background and Purpose—Walking is an essential activity for daily life and social
participation, and it is frequently limited after stroke. A lack of knee flexion during the swing …

Twenty researchers in the field of neuromuscular disorders from eight different countries
(USA, Canada, Spain, Italy, France, Belgium, The Netherlands, UK), and a patient …